MedPath

A study to compare the effects of Midazolam, Dexmedetomidine and Ketamine premedication on the recovery profile after anaesthesia

Not yet recruiting
Conditions
Measurement and Monitoring,
Registration Number
CTRI/2021/07/034859
Lead Sponsor
Dr Phindariiaki Wankhar
Brief Summary

A randomized double-blinded clinical trial to study the effects of 0.04 mg/kg of IV Midazolam, 0.05 mcg/kg of IV Dexmedetomidine and 0.25 mg/kg of IV Ketamine pre-medication in the recovery profile in 99 patients aged 18 to 60 years with ASA I and II undergoing major surgeries of less than 3 hours duration under balanced anaesthesia. The study will be conducted in the Department of Anaesthesiology, Regional Institute of Medical Sciences, Imphal, Manipur. The study drug will be given over 10 minutes before induction with Propofol. Post- operatively, recovery profile will be assessed in terms of emergence time, recovery time based on Modified Aldrete Score, time to first rescue analgesia based on Visual Analogue Scale (VAS), any episode of nausea/vomiting during the first one hour, any episode of dreaming, awareness on questioning post- operatively.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
99
Inclusion Criteria

ASA Grade I and II Undergoing major surgeries of duration less than 3 hours.

Exclusion Criteria
  • Hepatic, renal, neurological, cardiovascular and respiratory illnesses 2.
  • Allergy to any study drug 3.
  • Anticipated difficult airway.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Recovery profile after balanced anaesthesia1 hour
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Regional Institute of Medical Sciences

🇮🇳

West, MANIPUR, India

Regional Institute of Medical Sciences
🇮🇳West, MANIPUR, India
Dr Phindariiaki Wankhar
Principal investigator
8413078481
phindi07@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.